Back | Next |
home / stock / sngx / sngx message board
Subject | By | Source | When |
---|---|---|---|
$SNGX news out | subslover | investorshub | 11/03/2023 4:23:46 PM |
The trading last trade up | TruckingAngler | investorshub | 11/03/2023 4:00:14 PM |
$SNGX Price now up | fung_derf | investorshub | 11/03/2023 1:24:36 AM |
$SNGX Price now up | TruckingAngler | investorshub | 11/02/2023 8:22:11 AM |
short data if anyone is interested | fung_derf | investorshub | 11/01/2023 4:30:10 PM |
$SNGX short squeeze signal | TruckingAngler | investorshub | 10/31/2023 11:06:08 AM |
$SNGX Good read | fung_derf | investorshub | 10/31/2023 8:49:03 AM |
The trading | subslover | investorshub | 10/31/2023 7:59:41 AM |
$SNGX Price trading | TruckingAngler | investorshub | 10/31/2023 7:20:08 AM |
The now | BooDog | investorshub | 10/31/2023 5:52:12 AM |
$SNGX Price gaining last up | BooDog | investorshub | 10/31/2023 5:45:07 AM |
$SNGX MomentumIts gaining | TruckingAngler | investorshub | 10/31/2023 1:29:30 AM |
Price trading last trade up | TruckingAngler | investorshub | 10/31/2023 12:34:32 AM |
No insider dumping,they loading for some reason? Big | 81vette | investorshub | 09/06/2023 5:38:18 PM |
Trading natural today,no dilution,accumulation last 5 days | 81vette | investorshub | 09/06/2023 5:33:20 PM |
3Xs ave vol,2Xs buy vol,bids/demand growing | 81vette | investorshub | 09/06/2023 5:30:57 PM |
The biotech sector is draconian | Monksdream | investorshub | 08/19/2023 3:17:05 PM |
Nice work Schaber. Penny for your thoughts. $SNGX now | TruckingAngler | investorshub | 08/19/2023 3:13:52 PM |
$SNGX new 52 week low | Monksdream | investorshub | 08/15/2023 5:18:29 PM |
$SNGX new 52 week low | Monksdream | investorshub | 08/14/2023 6:12:35 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 10:20:00 ET July 18, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compa...
NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView is pleased to announce an exclusive Q&A session with Dr. Ellen Kim, discussing the promising interim results of Soligenix's ( Nasdaq:SNGX ) HyBryte™ from the ongoing investigator-initiated study (IIS). HyBryte...